Provided preclinical data indicates that Adipose-derived stromal cells (A.S.C.)prevent prostate cancer cell growth, causing prostate cancer cell apoptosis with reduced activity of BCL2L1 by miR-145, so it can be a new and favorable therapeutic strategy in patients with prostate cancer36. This evidence concerns the gene BCL2L1 and prostate cancer.